Lasko, Loren M.
Jakob, Clarissa G.
Edalji, Rohinton P.
Qiu, Wei
Montgomery, Debra
Digiammarino, Enrico L.
Hansen, T. Matt
Risi, Roberto M.
Frey, Robin
Manaves, Vlasios
Shaw, Bailin
Algire, Mikkel
Hessler, Paul
Lam, Lloyd T.
Uziel, Tamar
Faivre, Emily
Ferguson, Debra
Buchanan, Fritz G.
Martin, Ruth L.
Torrent, Maricel
Chiang, Gary G.
Karukurichi, Kannan
Langston, J. William
Weinert, Brian T.
Choudhary, Chunaram
de Vries, Peter
Kluge, Arthur F.
Patane, Michael A.
Van Drie, John H.
Wang, Ce
McElligott, David
Kesicki, Ed
Marmorstein, Ronen
Sun, Chaohong
Cole, Philip A.
Rosenberg, Saul H.
Michaelides, Michael R.
Lai, Albert
Bromberg, Kenneth D.
Article History
Received: 19 January 2017
Accepted: 22 August 2017
First Online: 27 September 2017
Change Date: 16 May 2018
Change Type: Correction
Change Details: In the originally published version of this Letter, authors Michael A. Patane, Arthur F. Kluge and Ce Wang were omitted from the author list; author 'Edward A. Kesicki' was misspelled; the Fig. 1a A-485 structure had an 'S' instead of a 'C' at the centre; Fig. 4d units were millimolar instead of micromolar; the headings were missing from the top of Extended Data Fig. 7e; and information specific to the authors M.A.P., A.F.K. and C.W. was missing from the 'Competing interests' statement. These errors have been corrected online.
Competing interests
: This study was sponsored by AbbVie. AbbVie contributed to the study design, research and interpretation of data, and to writing, reviewing and approving the publication. L.M.L, C.G.J., R.P.E, W.Q., D.Mo., E.L.D., T.M.H, R.M.R, R.F., V.M., B.S., M.A., P.H., L.T.L., T.U., E.F., D.F., F.G.B., M.T., G.G.C., C.S., M.R.M., S.H.R., A.L. and K.D.B. were employees of AbbVie at the time of the study. K.K., J.W.L., P.d.V., D.Mc., and E.K. were employees of Acylin which provided assets to AbbVie at the time of the study. AbbVie licensed and provided funding for these assets. R.M. and P.A.C. are co-founders of Acylin and consultants for AbbVie. A.F.K. and M.A.P. were consultants to Acylin at the time of the study. C.W. was an employee of BioDuro, which was contracted by Acylin at the time of the study.